Product Information_Qidong Gaitianli

Huaier Granules Won the Ranking List of Science and Technology Competitiveness of Large Varieties of Traditional Chinese Medicine in 2018

On December 26, 2018, the 4th Forum on large varieties of traditional Chinese medicine and the press conference of the report on scientific and technological competitiveness of large varieties of traditional Chinese medicine (2018 edition) was held in Beijing, and the Chinese society of traditional Chinese medicine solemnly released the report on scientific and technological competitiveness of large varieties of traditional Chinese medicine (2018 edition). The report was compiled by the Alliance of Large Varieties of Traditional Chinese Medicine in conjunction with Wanfang Data and the Research and Evaluation Office of the Chinese Society of Traditional Chinese Medicine. This forum is sponsored by the Chinese Society of Traditional Chinese Medicine, and hosted by the Alliance of Large Varieties of Traditional Chinese Medicine and the Alliance of Research-oriented Chinese Medicine Hospitals.

2018

Huai Qi Huang Granules Query Method Change Description

Starting from batch HJ18 (September 18, 2018), the words "China Drug Electronic Supervision Code" in the code assignment area of small boxes and large boxes have been changed to "Code Rest assured and Traceability Code". The inquiry method has been changed from the original three methods of "telephone inquiry, short message inquiry and website inquiry" to "mobile phone Taobao scan code inquiry" and "telephone inquiry.

2018

Huaier Research Appears on International Stage to Sing Chinese Voice

From September 4 to 7, the 13th International Hepatobiliary and Pancreatic Association World Congress was held in Geneva, Switzerland. Nearly 3,000 delegates, including surgeons and researchers from all over the world, had a fruitful in-depth dialogue to discuss the current hot spots and difficulties in the diagnosis and treatment of hepatobiliary and pancreatic diseases in the world.

2018

Strengthening the Construction of Big Data Cloud Platform for Scientific Research and Expecting to Provide Chinese Solutions for Human Health

The "Multicenter, Randomized Parallel Controlled Clinical Study of Huaier Granules in the Prevention of Recurrence and Metastasis after Radical Resection of Liver Cancer" by Academician Chen Xiaoping was published in Gut, the official journal of the British Society of Gastroenterology. "Er Granules" is currently the only effective drug that can prevent recurrence and metastasis after tumor surgery.

2018

A real-world research program seminar on Huaier Granules for the prevention of postoperative recurrence and metastasis of colorectal cancer was held in Zhengzhou

On September 22, 2017, the "Real World Research Program Seminar on Huaier Granules for Preventing Recurrence and Metastasis of Colorectal Cancer" organized by Qidong Gaitianli Pharmaceutical Co., Ltd. was successfully held at Sheraton Zhengzhou Meisheng Hotel.

2017

Interpretation of Primary Liver Cancer Diagnosis and Treatment Standards and Report of Huaier Granule Research Results Seminar Held in Shanghai

On September 17, 2017, the seminar "Interpretation of Primary Liver Cancer Diagnosis and Treatment Standards and Report of Huaier Granules Research Results" organized by Gaitianli Pharmaceuticals was successfully held on the banks of the Huangpu River in the picturesque Pudong, Shanghai.

2017

Special Report on the Research Results of Huaier Granules at the Seventh Hepatobiliary and Pancreatic Conference in Guangdong Province

On August 19, 2017, sponsored by the Guangdong Medical Association, undertaken by the Guangdong Provincial Hepatobiliary and Pancreatic Surgery Branch, and co-organized by the First Affiliated Hospital of Sun Yat-sen University, the 7th Academic Conference of Hepatobiliary and Pancreatic Surgery of the Guangdong Medical Association was held in Guangzhou Baiyun Wanda Hilton Hotel ", the meeting was unprecedented, with 1800 participants.

2017

A real-world research program seminar on the effectiveness of Huaiqihuang granules in the treatment of primary nephrotic syndrome in children was held in Hangzhou.

On the morning of June 10, 2017, the seminar on "real world research on the effectiveness of huaiqihuang granules in the treatment of primary nephrotic syndrome in children" sponsored by qidong gaitianli pharmaceutical co., ltd. was held in Shangri-La hotel in Hangzhou city. this is the second large sample clinical study of huaiqihuang granules after the real world study of 3000 cases of bronchial asthma in children.

2017

< 1 2 3 4 5 >

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Address

1166 West Nanyuan Road, Qidong Economic Development Zone, Jiangsu Province

Telephone

0086-513-83101860 / 0086-513-83321533

E-mail

yonghu@gaitianli.com.cn

Mobile website

Public Number

Business License